News – Article
Media release for February 12, 2014
IG Living! Magazine, the only publication dedicated to patients who are treated with immune globulin (IG) products and their care providers, celebrates its eight year anniversary with the February-March 2014 issue. The recipient of numerous awards, IG Living has long been a definitive source of information and inspiration to those in the IG community.
“Our mission is to support chronically ill patients through education, communication and advocacy,” says Editor-in-Chief Ronale Tucker Rhodes. “Our subscribers rely on IG Living’s content for timely information about their medication, treatments and reimbursement issues, as well as helpful advice on lifestyle concerns facing those impacted by rare disease.”
Published by FFF Enterprises, Inc., the nation’s most trusted distributor of biopharmaceuticals, IG Living continues to find new and innovative ways to reach its rapidly expanding audience. Launched in 2006, the free, bi-monthly publication is distributed to nearly 30,000 readers — direct to patients and their physicians’ offices. IG Living also reaches thousands of readers through its eNewsletter, website, blog and Facebook pages, including more than 32,000 unique online visitors and more than 100,000 page views annually.
Feature articles for the February-March 2014 issue include an in-depth look at the challenges of working while chronically ill and the benefits of joining a patient registry. For more information or to subscribe, visit www.IGLiving.com.
About IG LivingIG Living is the only magazine dedicated to patients who are treated with immune globulin (IG) products and to their care providers. IG Living launched its first bimonthly issue in February-March 2006; today, the IG Living print magazine is distributed to nearly 30,000 readers — direct to patients and their physicians’ offices. Regular features include immune globulin lifestyle and treatment options, autoimmune disease updates, patient profiles, young adult and teen perspectives, parenting and question-and-answer columns, clinical research news, product and manufacturer news, reimbursement issues, and much more. IG Living also reaches thousands of readers through its eNewsletter, website and Facebook pages, including more than 32,000 unique online visitors and more than 100,000 page views annually. The IG Living Facebook page, Teen Group and blog provide connection and support to more than 2,000 fans and an average weekly total reach of more than 10,000 social media users. IG Living is published by FFF Enterprises, Inc.
About FFF Enterprises
Temecula-based FFF Enterprises is the largest and most trusted distributor of plasma products, vaccines and other biopharmaceuticals in the U.S. Founded in 1988, FFF is now in its 26th year with more than a billion dollars in annual sales and a flawless safety track record. FFF has taken a leadership position in regard to supply chain safety and innovation, setting new standards and pioneering industry firsts. FFF’s commitment to Guaranteed Channel Integrity™ ensures that products are purchased only from the manufacturer and shipped only to healthcare providers, with additional steps taken to safely store, handle and ship products to ensure patient safety is never compromised. FFF’s proprietary systems, Verified Electronic Pedigree™ and Lot-Track™, provide verification of this secure channel; the company’s innovative VERIFIED™ Inventory Program - Consignment (VIPc) utilizes state-of-the-art RFID technology to continuously monitor the inventory of critical-care products; and FFF’s MyFluVaccine (www.MyFluVaccine.com) and VaxAmerica (www.VaxAmerica.com) are revolutionary vaccination programs that have added a new level of safety, convenience and reliability to both healthcare providers and consumers.